













BubbleJect K+ Device
Low Cost Pre-Filled Injectable Medicine Device
Gates Foundation
In low resource settings, injectable medicines traditionally rely on multi-dose glass vials and syringes, demanding sterile environments, trained staff, and time – often unavailable in rural clinics. This causes wastage, contamination risks, and delays, reducing global access to care. BubbleJect provides a solution by offering an affordable, safe, single-use device with reuse-prevention features, an intuitive design, and integrated Blow-Fill-Seal technology. Compatible with drug manufacturers and last-mile delivery, it simplifies administration, and empowers the end user and health workers. Our project is supported by The Gates Foundation.
Client / ManufacturerDesign
Gates Foundation
Seattle, Washington, USRommelag SE & Co. KG
Sulzbach-Laufen, DEApiJect Research UK LTD
London, GBMarc Koska, Max Hannon, Maria Inacio, George FryettDate of Launch
2026
Target Regions
Africa, Asia, South America
Target Groups
Consumers / Users, Public Sector / Government